Starch Placebo

DRUG5 trials

Conditions

Fatty LiverFatty Liver DiseaseFatty Liver, Non-alcoholic Fatty Liver Disease, NAFLDFatty Liver, NonalcoholicHematopoietic Stem Cell TransplantationInflammationIrritable Bowel SyndromeMAFLD

Phase 2

Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients

CompletedNCT02763033

University of Michigan Rogel Cancer CenterHematopoietic Stem Cell Transplantation

Start: 2017-04-26End: 2025-12-29Updated: 2026-03-24

Neuroprotection of Memantine and Rosuvastatin

Not yet recruitingNCT07504198

Tanta UniversityPeripheral Nerve Disease

Start: 2026-03-01End: 2027-05-01Target: 46Updated: 2026-03-31

Phase 3

Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment

NCT02504060

Third Military Medical UniversityIrritable Bowel Syndrome

Start: 2015-06-30End: 2017-07-31Target: 720Updated: 2015-07-21

Unknown Phase

Effect of Vitamin D and Folic Acid on Mild Cognitive Impairment

Active, not recruitingNCT07486141

Capital Medical UniversityMild Cognitive Impairment

Start: 2024-11-01End: 2026-06-01Updated: 2026-03-20

Impact of Ganoderma Lucidum on NRF2 Levels and Antioxidant Status in Metabolic Asscociated Fatty Liver Disease (GL-MAFLD-NRF2 Study)

Enrolling by invitationNCT07564947

University of Agriculture, PeshawarFatty Liver, Fatty Liver Disease, Fatty Liver, Nonalcoholic +4

Start: 2026-04-28End: 2027-04-20Target: 40Updated: 2026-05-04

Related Papers

Feasibility of a dietary intervention to modify gut microbial metabolism in patients with hematopoietic stem cell transplantation.

2023-10-1925 citations

Rational Modification of Intestinal Microbiome and Metabolites after Allogeneic Hematopoietic Stem Cell Transplantation with Resistant Starch: A Pilot Study